Advertisement

Deregulation of miR-324/KISS1/kisspeptin in early ectopic pregnancy: mechanistic findings with clinical and diagnostic implications

Published:January 29, 2019DOI:https://doi.org/10.1016/j.ajog.2019.01.228

      Background

      Ectopic pregnancy is a life-threatening condition for which novel screening tools that would enable early accurate diagnosis would improve clinical outcomes. Kisspeptins, encoded by KISS1, play an essential role in human reproduction, at least partially by regulating placental function and possibly embryo implantation. Kisspeptin levels are elevated massively in normal pregnancy and reportedly altered in various gestational pathologic diseases. Yet, the pathophysiologic role of KISS1/kisspeptin in ectopic pregnancy has not been investigated previously.

      Objective

      The purpose of this study was to evaluate changes of KISS1/kisspeptin levels in ectopic pregnancy and their underlaying molecular mechanisms and to ascertain the diagnostic implications of these changes.

      Study Design

      A total of 122 women with normal pregnancy who underwent voluntary termination of pregnancy and 84 patients who experienced tubal ectopic pregnancy were recruited. Measurements of plasma kisspeptins and KISS1 expression analyses in human embryonic/placental tissue were conducted in ectopic pregnancy and voluntary termination of pregnancy control subjects during the early gestational window (<12 weeks). Putative microRNA regulators of KISS1 were predicted in silico, followed by expression analyses of selected microRNAs and validation of repressive interactions in vitro. Circulating levels of these microRNAs were also assayed in ectopic pregnancy vs voluntary termination of pregnancy.

      Results

      Circulating kisspeptins gradually increased during the first trimester of normal pregnancy but were reduced markedly in ectopic pregnancy. This profile correlated with the expression levels of KISS1 in human embryonic/placental tissue, which increased in voluntary termination of pregnancy but remained suppressed in ectopic pregnancy. Bioinformatic predictions and expression analyses identified miR-27b-3p and miR-324-3p as putative repressors of KISS1 in human embryonic/placental tissue at <12 weeks gestation, when expression of microRNAs was low in voluntary termination of pregnancy control subjects but significantly increased in ectopic pregnancy. Yet, a significant repressive interaction was documented only for miR-324-3p, occurring at the predicted 3’-UTR of KISS1. Interestingly, circulating levels of miR-324-3p, but not of miR-27b-3p, were suppressed distinctly in ectopic pregnancy, despite elevated tissue expression of the pre-microRNA. A decision-tree model that used kisspeptin and miR-324-3p levels was successful in discriminating ectopic pregnancy vs voluntary termination of pregnancy, with a receiver-operating characteristic area under the curve of 0.95±0.02 (95% confidence interval).

      Conclusion

      Our results document a significant down-regulation of KISS1/kisspeptins in early stages of ectopic pregnancy via, at least partially, a repressive interaction with miR-324-3p. Our data identify circulating kisspeptins and miR-324-3p as putative biomarkers for accurate screening of ectopic pregnancy at early gestational ages.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Barnhart K.T.
        Clinical practice: ectopic pregnancy.
        N Engl J Med. 2009; 361: 379-387
        • Farquhar C.M.
        Ectopic pregnancy.
        Lancet. 2005; 366: 583-591
        • Taran F.A.
        • Kagan K.O.
        • Hubner M.
        • Hoopmann M.
        • Wallwiener D.
        • Brucker S.
        The diagnosis and treatment of ectopic pregnancy.
        Dtsch Arztebl Int. 2015; 112 (quiz 4-5): 693-703
        • Goyaux N.
        • Leke R.
        • Keita N.
        • Thonneau P.
        Ectopic pregnancy in African developing countries.
        Acta Obstet Gynecol Scand. 2003; 82: 305-312
        • Doubilet P.M.
        • Benson C.B.
        • Bourne T.
        • et al.
        Diagnostic criteria for nonviable pregnancy early in the first trimester.
        N Engl J Med. 2013; 369: 1443-1451
        • Majeed H.
        • Hojgaard A.
        • Johannesen P.
        • Ladefoged M.L.
        • Forman A.
        • Bor P.
        Predictive value of serum human chorionic gonadotropin ratio, progesterone and inhibin A for expectant management of early pregnancies of unknown location.
        Eur J Obstet Gynecol Reprod Biol. 2012; 165: 66-69
        • Guha S.
        • Ayim F.
        • Ludlow J.
        • et al.
        Triaging pregnancies of unknown location: the performance of protocols based on single serum progesterone or repeated serum hCG levels.
        Hum Reprod. 2014; 29: 938-945
        • Zou S.
        • Li X.
        • Feng Y.
        • et al.
        Comparison of the diagnostic values of circulating steroid hormones, VEGF-A, PIGF, and ADAM12 in women with ectopic pregnancy.
        J Transl Med. 2013; 11: 44
        • Feng C.
        • Chen Z.Y.
        • Zhang J.
        • Xu H.
        • Zhang X.M.
        • Huang X.F.
        Clinical utility of serum reproductive hormones for the early diagnosis of ectopic pregnancy in the first trimester.
        J Obstet Gynaecol Res. 2013; 39: 528-535
        • Van Calster B.
        • Bobdiwala S.
        • Guha S.
        • et al.
        Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two-step triage protocol.
        Ultrasound Obstet Gynecol. 2016; 48: 642-649
        • Rausch M.E.
        • Sammel M.D.
        • Takacs P.
        • Chung K.
        • Shaunik A.
        • Barnhart K.T.
        Development of a multiple marker test for ectopic pregnancy.
        Obstet Gynecol. 2011; 117: 573-582
        • Pinilla L.
        • Aguilar E.
        • Dieguez C.
        • Millar R.P.
        • Tena-Sempere M.
        Kisspeptins and reproduction: physiological roles and regulatory mechanisms.
        Physiol Rev. 2012; 92: 1235-1316
        • De Roux N.
        • Genin E.
        • Carel J.C.
        • Matsuda F.
        • Chaussain J.L.
        • Milgrom E.
        Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.
        Proc Natl Acad Sci U S A. 2003; 100: 10972-10976
        • Seminara S.B.
        • Messager S.
        • Chatzidaki E.E.
        • et al.
        The GPR54 gene as a regulator of puberty.
        N Engl J Med. 2003; 349: 1614-1627
        • Topaloglu A.K.
        • Tello J.A.
        • Kotan L.D.
        • et al.
        Inactivating KISS1 mutation and hypogonadotropic hypogonadism.
        N Engl J Med. 2012; 366: 629-635
        • Avendano M.S.
        • Vazquez M.J.
        • Tena-Sempere M.
        Disentangling puberty: novel neuroendocrine pathways and mechanisms for the control of mammalian puberty.
        Hum Reprod Update. 2017; 23: 737-763
        • Bhattacharya M.
        • Babwah A.V.
        Kisspeptin: beyond the brain.
        Endocrinology. 2015; 156: 1218-1227
        • Babwah A.V.
        Uterine and placental KISS1 regulate pregnancy: what we know and the challenges that lie ahead.
        Reproduction. 2015; 150: R121-R128
        • Leon S.
        • Fernadois D.
        • Sull A.
        • et al.
        Beyond the brain-peripheral kisspeptin signaling is essential for promoting endometrial gland development and function.
        Sci Rep. 2016; 6: 29073
        • Bilban M.
        • Ghaffari-Tabrizi N.
        • Hintermann E.
        • et al.
        Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts.
        J Cell Sci. 2004; 117: 1319-1328
        • Horikoshi Y.
        • Matsumoto H.
        • Takatsu Y.
        • et al.
        Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans.
        J Clin Endocrinol Metab. 2003; 88: 914-919
        • Logie J.J.
        • Denison F.C.
        • Riley S.C.
        • et al.
        Evaluation of kisspeptin levels in obese pregnancy as a biomarker for pre-eclampsia.
        Clin Endocrinol (Oxf). 2012; 76: 887-893
        • Armstrong R.A.
        • Reynolds R.M.
        • Leask R.
        • Shearing C.H.
        • Calder A.A.
        • Riley S.C.
        Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia.
        Prenat Diagn. 2009; 29: 982-985
        • Jayasena C.N.
        • Abbara A.
        • Izzi-Engbeaya C.
        • et al.
        Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage.
        J Clin Endocrinol Metab. 2014; 99: E2652-E2660
        • Sullivan-Pyke C.
        • Haisenleder D.J.
        • Senapati S.
        • et al.
        Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy.
        Fertil Steril. 2018; 109: 137-141.e2
        • Sayed D.
        • Abdellatif M.
        MicroRNAs in development and disease.
        Physiol Rev. 2011; 91: 827-887
        • Feng Y.
        • Zou S.
        • Weijdegard B.
        • et al.
        The onset of human ectopic pregnancy demonstrates a differential expression of miRNAs and their cognate targets in the Fallopian tube.
        Int J Clin Exp Pathol. 2014; 7: 64-79
        • Lozoya T.
        • Dominguez F.
        • Romero-Ruiz A.
        • et al.
        The Lin28/Let-7 system in early human embryonic tissue and ectopic pregnancy.
        PLoS One. 2014; 9: e87698
        • Dominguez F.
        • Moreno-Moya J.M.
        • Lozoya T.
        • et al.
        Embryonic miRNA profiles of normal and ectopic pregnancies.
        PLoS One. 2014; 9: e102185
        • Cretoiu D.
        • Xu J.
        • Xiao J.
        • Suciu N.
        • Cretoiu S.M.
        Circulating microRNAs as potential molecular biomarkers in pathophysiological evolution of pregnancy.
        Dis Markers. 2016; 2016: 3851054
        • Kontomanolis E.N.
        • Kalagasidou S.
        • Fasoulakis Z.
        MicroRNAs as potential serum biomarkers for early detection of ectopic pregnancy.
        Cureus. 2018; 10: e2344
        • Zhao Z.
        • Zhao Q.
        • Warrick J.
        • et al.
        Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy.
        Clin Chem. 2012; 58: 896-905
        • Lu Q.
        • Yan Q.
        • Xu F.
        • et al.
        MicroRNA-873 is a potential serum biomarker for the detection of ectopic pregnancy.
        Cell Physiol Biochem. 2017; 41: 2513-2522
        • Miura K.
        • Higashijima A.
        • Mishima H.
        • et al.
        Pregnancy-associated microRNAs in plasma as potential molecular markers of ectopic pregnancy.
        Fertil Steril. 2015; 103: 1202-1208.e1
        • Zhang S.
        • Sun Q.
        • Jiang X.
        • Gao F.
        Clinical significance of expression of hsa-mir-1247 and hsa-mir-1269a in ectopic pregnancy due to salpingitis.
        Exp Ther Med. 2018; 15: 4901-4905
        • Lomniczi A.
        • Wright H.
        • Ojeda S.R.
        Epigenetic regulation of female puberty.
        Front Neuroendocrinol. 2015; 36: 90-107
        • Sangiao-Alvarellos S.
        • Manfredi-Lozano M.
        • Ruiz-Pino F.
        • et al.
        Changes in hypothalamic expression of the Lin28/let-7 system and related microRNAs during postnatal maturation and after experimental manipulations of puberty.
        Endocrinology. 2013; 154: 942-955
        • Dhillo W.S.
        • Chaudhri O.B.
        • Patterson M.
        • et al.
        Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males.
        J Clin Endocrinol Metab. 2005; 90: 6609-6615
        • Dhillo W.S.
        • Savage P.
        • Murphy K.G.
        • et al.
        Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment.
        Am J Physiol Endocrinol Metab. 2006; 291: E878-E884
        • Ramachandran R.
        • Patterson M.
        • Murphy K.G.
        • et al.
        Preanalytical factors affecting RIA measurement of plasma kisspeptin.
        Clin Chem. 2008; 54: 615-617
        • Kim J.-H.
        Estimating classification error rate: repeated cross-validation, repeated hold-out and bootstrap.
        Computational Statistics & Data Analysis. 2009; 53: 3735-3745
        • DeLong E.R.
        • DeLong D.M.
        • Clarke-Pearson D.L.
        Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
        Biometrics. 1988; 44: 837-845
        • Lorincz M.C.
        • Schubeler D.
        Evidence for converging DNA methylation pathways in placenta and cancer.
        Dev Cell. 2017; 43: 257-258
        • Matjila M.
        • Millar R.
        • van der Spuy Z.
        • Katz A.
        Elevated placental expression at the maternal-fetal interface but diminished maternal circulatory kisspeptin in preeclamptic pregnancies.
        Pregnancy Hypertens. 2016; 6: 79-87
        • Taylor J.
        • Pampillo M.
        • Bhattacharya M.
        • Babwah A.V.
        Kisspeptin/KISS1R signaling potentiates extravillous trophoblast adhesion to type-I collagen in a PKC- and ERK1/2-dependent manner.
        Mol Reprod Dev. 2014; 81: 42-54
        • Calder M.
        • Chan Y.M.
        • Raj R.
        • et al.
        Implantation failure in female Kiss1-/- mice is independent of their hypogonadic state and can be partially rescued by leukemia inhibitory factor.
        Endocrinology. 2014; 155: 3065-3078
        • Gaytan M.
        • Castellano J.M.
        • Roa J.
        • Sanchez-Criado J.E.
        • Tena-Sempere M.
        • Gaytan F.
        Expression of KiSS-1 in rat oviduct: possible involvement in prevention of ectopic implantation?.
        Cell Tissue Res. 2007; 329: 571-579
        • Lomniczi A.
        • Ojeda S.R.
        The emerging role of epigenetics in the regulation of female puberty.
        Endocr Dev. 2016; 29: 1-16
        • Lytle J.R.
        • Yario T.A.
        • Steitz J.A.
        Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5’ UTR as in the 3’ UTR.
        Proc Natl Acad Sci U S A. 2007; 104: 9667-9672
        • Orom U.A.
        • Nielsen F.C.
        • Lund A.H.
        MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation.
        Mol Cell. 2008; 30: 460-471